Scolaris Content Display Scolaris Content Display

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
Figuras y tablas -
Figure 1

Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
Figuras y tablas -
Figure 2

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 1 Oxygen saturation measured by pulse oximetry: inpatient and outpatient settings.
Figuras y tablas -
Analysis 1.1

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 1 Oxygen saturation measured by pulse oximetry: inpatient and outpatient settings.

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 2 Sub‐analysis ‐ oxygen saturation (outpatients treated with albuterol/salbutamol).
Figuras y tablas -
Analysis 1.2

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 2 Sub‐analysis ‐ oxygen saturation (outpatients treated with albuterol/salbutamol).

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 3 Improvement in clinical score (dichotomous).
Figuras y tablas -
Analysis 1.3

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 3 Improvement in clinical score (dichotomous).

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 4 Average clinical score after treatment: by treatment setting (continuous).
Figuras y tablas -
Analysis 1.4

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 4 Average clinical score after treatment: by treatment setting (continuous).

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 5 Sub‐analysis ‐ average clinical score (outpatients treated with albuterol/salbutamol).
Figuras y tablas -
Analysis 1.5

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 5 Sub‐analysis ‐ average clinical score (outpatients treated with albuterol/salbutamol).

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 6 Hospital admission after treatment (outpatients treated with albuterol or salbutamol).
Figuras y tablas -
Analysis 1.6

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 6 Hospital admission after treatment (outpatients treated with albuterol or salbutamol).

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 7 Duration of hospitalization (inpatients).
Figuras y tablas -
Analysis 1.7

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 7 Duration of hospitalization (inpatients).

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 8 Time to resolution of illness (outpatients).
Figuras y tablas -
Analysis 1.8

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 8 Time to resolution of illness (outpatients).

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 9 Sensitivity analysis ‐ oxygen saturation low risk of bias studies.
Figuras y tablas -
Analysis 1.9

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 9 Sensitivity analysis ‐ oxygen saturation low risk of bias studies.

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 10 Sensitivity analysis ‐ average clinical score low risk of bias studies.
Figuras y tablas -
Analysis 1.10

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 10 Sensitivity analysis ‐ average clinical score low risk of bias studies.

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 11 Sensitivity analysis ‐ average clinical score using RDAI (outpatients).
Figuras y tablas -
Analysis 1.11

Comparison 1 Bronchodilators compared to placebo for treatment of acute bronchiolitis, Outcome 11 Sensitivity analysis ‐ average clinical score using RDAI (outpatients).

Comparison 1. Bronchodilators compared to placebo for treatment of acute bronchiolitis

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Oxygen saturation measured by pulse oximetry: inpatient and outpatient settings Show forest plot

25

1242

Mean Difference (IV, Random, 95% CI)

‐0.43 [‐0.92, 0.06]

1.1 Inpatient studies

12

495

Mean Difference (IV, Random, 95% CI)

‐0.62 [‐1.40, 0.16]

1.2 Outpatient studies

13

747

Mean Difference (IV, Random, 95% CI)

‐0.25 [‐0.61, 0.11]

2 Sub‐analysis ‐ oxygen saturation (outpatients treated with albuterol/salbutamol) Show forest plot

10

572

Mean Difference (IV, Random, 95% CI)

‐0.19 [‐0.59, 0.21]

3 Improvement in clinical score (dichotomous) Show forest plot

7

365

Odds Ratio (M‐H, Random, 95% CI)

0.18 [0.06, 0.50]

3.1 Inpatient

5

208

Odds Ratio (M‐H, Random, 95% CI)

0.20 [0.05, 0.79]

3.2 Outpatient

2

157

Odds Ratio (M‐H, Random, 95% CI)

0.11 [0.01, 1.46]

4 Average clinical score after treatment: by treatment setting (continuous) Show forest plot

21

1086

Std. Mean Difference (IV, Random, 95% CI)

‐0.30 [‐0.54, ‐0.05]

4.1 Inpatient studies

9

416

Std. Mean Difference (IV, Random, 95% CI)

‐0.14 [‐0.41, 0.12]

4.2 Outpatient studies

12

670

Std. Mean Difference (IV, Random, 95% CI)

‐0.42 [‐0.79, ‐0.06]

5 Sub‐analysis ‐ average clinical score (outpatients treated with albuterol/salbutamol) Show forest plot

9

532

Std. Mean Difference (IV, Random, 95% CI)

‐0.36 [‐0.83, 0.11]

6 Hospital admission after treatment (outpatients treated with albuterol or salbutamol) Show forest plot

11

710

Odds Ratio (M‐H, Fixed, 95% CI)

0.75 [0.46, 1.21]

6.1 Nebulized

8

404

Odds Ratio (M‐H, Fixed, 95% CI)

0.77 [0.44, 1.33]

6.2 Oral in ED setting

1

37

Odds Ratio (M‐H, Fixed, 95% CI)

0.32 [0.03, 3.21]

6.3 Oral at home

2

269

Odds Ratio (M‐H, Fixed, 95% CI)

0.86 [0.28, 2.64]

7 Duration of hospitalization (inpatients) Show forest plot

6

349

Mean Difference (IV, Fixed, 95% CI)

0.06 [‐0.27, 0.39]

8 Time to resolution of illness (outpatients) Show forest plot

2

269

Mean Difference (IV, Fixed, 95% CI)

0.29 [‐0.43, 1.00]

9 Sensitivity analysis ‐ oxygen saturation low risk of bias studies Show forest plot

15

793

Mean Difference (IV, Random, 95% CI)

‐0.38 [‐0.75, 0.00]

9.1 Inpatient

4

210

Mean Difference (IV, Random, 95% CI)

‐0.65 [‐1.77, 0.48]

9.2 Outpatient

11

583

Mean Difference (IV, Random, 95% CI)

‐0.29 [‐0.66, 0.08]

10 Sensitivity analysis ‐ average clinical score low risk of bias studies Show forest plot

15

734

Std. Mean Difference (IV, Random, 95% CI)

‐0.22 [‐0.41, ‐0.03]

10.1 Inpatient

5

228

Std. Mean Difference (IV, Random, 95% CI)

0.01 [‐0.35, 0.37]

10.2 Outpatient

10

506

Std. Mean Difference (IV, Random, 95% CI)

‐0.32 [‐0.54, ‐0.09]

11 Sensitivity analysis ‐ average clinical score using RDAI (outpatients) Show forest plot

4

240

Std. Mean Difference (IV, Random, 95% CI)

‐0.11 [‐0.48, 0.25]

Figuras y tablas -
Comparison 1. Bronchodilators compared to placebo for treatment of acute bronchiolitis